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Abstract: Hematogones are normal B-lymphoid precursors that multiply in the bone marrow of small children and of adults 
with ferropenic anaemia, neuroblastoma or idiopathic thrombocytopenic purpura. They are not normally found in peripheral 
blood, and the immunophenotype is virtually indistinguishable from that of B lymphoblasts. We discuss the case of a 
3-month infant with an active cytomegalovirus infection, with hepatitis and pancytopenia associated with 13% hematogones 
in the bone marrow.
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Introduction
Hematogones are B-lymphocyte precursors that are made apparent by the existence of a uniform nuclear 
chromatin, by the scarce presence of cellular cytoplasm in bone marrow extension, by the coexpression 
of CD-10, CD-38 and CD-19, and by the non expression of surface immunoglobulin. They are found 
in small concentrations in healthy people, but their numbers may increase among children or adults 
undergoing various pathological processes, with lymphomas, non-neoplastic blood cytopenias, post-
chemotherapy, post-bone marrow transplant and HIV being the most common such situations [1, 2]. In 
some patients, hematogones may represent over 50% of bone marrow cellularity; in such cases, these 
cells can give rise to problems of differential diagnosis with acute lymphoblastic leukemia or lympho-
blastic lymphoma, due to the considerable similarity in their cell morphology. Occasional reports have 
been made of the presence of hematogones in patients with myeloblastic leukemia or Down syndrome 
[3]. Hematogones have also been identiﬁ  ed in the cells of the bone marrow of premature neonates 
several weeks after birth, with a presence of up to 25% at two weeks of life [4]. Exceptionally, hema-
togones have been observed in the bone marrow extension of patients with cytomegalovirus infection 
or thrombocytopenia [5]. Although there have been reports of an increase in the percentage of hema-
togones in patients with immune-mediated thrombocytopenia, there does not seem to be a proven rela-
tion between the intensity of the thrombopenia, as assessed by a count of platelets in the peripheral 
blood, and the percentage of hematogones in the bone marrow [2].
We describe the case of a 3-month infant with active cytomegalovirus infection with hepatitis and 
pancytopenia, associated with a presence of 13% hematogones in the bone marrow.
Case Report
Infant aged 3 months, born prematurely (at 35 weeks’ gestational age) with a weight at birth of 
3100 g, admitted to the Neonatal Unit at our hospital. Discharged after one week, in view of the 
absence of nutritional, respiratory or metabolic disorders. Brought to the Emergency Service at our 
hospital after suffering high temperatures over three days. Physical examination revealed only an 
unusually pale skin and mucosal surfaces, together with a hepatosplenomegaly of 3 cm beneath the 
costal margin; the abdomen was soft and not tender to palpation. No wheezing was heard and the 
heart tone was normal.438
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Peripheral blood analysis
47% mature lymphocytes, 2% NK cells, 14% 
B lymphocytes, absence of B-precursor cells with 
CD20/CD10 expression. The remaining cells 
were composed of mature granulocyte. Leucocytes 
4.3 × 10
3/µl, Hemoglobin 8 g/dl, Haematocrit 
26.6%, Platelets 119 × 10
3/µl, Glucose 4.8 mmol/
L, Creatinine 0.027 mmol/L, Urea 1.7 mmol/L, 
Uric acid 0.030 mmol/L, Total cholesterol 
3.02 mmol/L, Triglycerides 2.56 mmol/L, AST 
520 U/L, ALT 403 U/L, Gammaglutamyl-
transpeptidase 262 U/L, Alkaline phosphatase 
209 U/L, Total bilirubin 0.021 mmol/L, Calcium 
2.37 mmol/L, Phosphorus 1.58 mmol/L, Iron 
0.006 mmol/L, Sodium 140 mmol/L, Potassium 
5.1 mmol/L, LDH 1083 U/L.
Bone marrow analysis
5% blasts (myeloids and lymphoids), 7% mature 
lymphocytes (3% CD4 T cells, 3% T CD8 cells, 
1% NK cells), 1% B lymphocytes, 15% pre-B cells 
with CD20/CD10 expression, 2% monocytes. 
Negative expression of CD-44 and CD-54. The 
remaining cells were mainly comprised of the 
mature granulocytic myeloid series.
Hemoculture, uroculture, coproculture and 
cerebrospinal ﬂ  uid culture: negative.
IgM serology to cytomegalovirus: positive. 
Cytomegalovirus antigen in urine: positive.
HIV, Epstein-Barr, Toxoplasma, Parvovirus 
B19, Lues disease, Mycoplasma pneumoniae, 
Brucella, Chlamidia, Hepatitis B and A, Rubeola, 
Leishmania: negative.
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Figure 1. Analysis of the bone marrow by ﬂ  ow cytometry. Note the positive expression of the CD19 marker of the B lymphocytes (D), the 
gradual expression of CD20 (B) and the expression of surface immunoglobulins. Also detected were cells with a positive expression with a 
polyclonal pattern (the expression of kappa and lambda light chains) and cells that do not express IgS (C).439
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Mantoux: negative. Eye background: normal. 
Abdominal radiography conﬁ  rmed the existence 
of hepatosplenomegaly and the absence of free 
peritoneal liquid. Chest radiology showed normal 
pulmonary parenchma, with no appearance of 
cardiomegaly.
The patient’s temperature returned to normal 
after 12 days; the patient remained free of fever 
for 6 days, after which it returned; blood and urine 
cultures were negative. The count for the white, 
red blood cells and megakaryocytic series remained 
unchanged. The patient was treated initially with 
ganciclovir at a dose of 25 mg/12 h. Hematologic 
and biochemical parameters subsequently returned 
to normal, and the patient remained clinically 
asymptomatic.
Discussion
Hematogones are normal B-lymphoid precursors 
that multiply in the bone marrow of small children 
and of adults with ferropenic anaemia, neuroblas-
toma or idiopathic thrombocytopenic purpura. 
They also occur frequently in regenerative bone 
marrow after chemotherapy or bone marrow trans-
plant, but are not normally found in peripheral 
blood. The immunophenotype is virtually indistin-
guishable from that of B lymphoblasts. Thus, these 
cells express markers associated with lympho-
blasts, such as TdT, CD10 and CD34. What dif-
ferentiates them from the latter is the continuity of 
the antigen expression, which means that hemato-
gones are undergoing a process of maturation, and 
so it is possible to detect the gradual expression of 
certain antigens, for example CD20 and surface 
immunoglobulins.
The presence of hematogones may create some 
confusion in ﬂ  ow cytometry analysis with the cell-
count of acute lymphoblastic leukemia in the bone 
marrow, given the similarity of its immunophenotype 
to that of pre-B lymphoblasts. Various authors have 
reported the positivity of hematogones to CD-10, 
CD-19, CD-20 and HLA-DR [5], and also that 
hematogones may occasionally express TdT and 
CD-34. The negativity to CD-44 and CD-54 has 
been used to discriminate between hematogones 
and leukemic blasts [6]. In the present case, we 
observed the expression of 15% CD-20/CD-10 
lymphoblasts in the bone marrow.
The presence of hematogones has been reported 
among children during the process of cellular 
regeneration of the bone marrow, following certain 
viral infections [6]; however, there are very few 
references in the literature to the presence of hema-
togones in the bone marrow following cytomega-
lovirus infection [5].
We conclude that during infancy the diagnosis 
of acute lymphoblastic leukemia of the pre-B cells 
should be explicitly distinguished from the benign 
proliferative states of pre-B cells (hematogones), 
especially after infection by cytomegalovirus.
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